1,3,5-Triazine-2,4,6-triamine,N2,N2,N4,N4,N6,N6-hexamethyl-
- 中文别名:六甲密胺
- 中文释义:六甲蜜胺;六甲三聚氰胺;2,4,6-三(二甲氨基)均三嗪;六甲聚腈胺
- 英文别名:hexamethylmelamine;
Altretamine;
Hexalen;
Hexastat;
NC 195;
N,N,N',N',N'',N''-hexamethyl-1,3,5-triazine-2,4,6-triamine;
N2,N2,N4,N4,N6,N6-hexamethyl-1,3,5-triazine-2,4,6-triamine;
HMM;
N,N,N’,N’,N″,N″-hexamethyl-1,3,5-triazine-2,4,6-triamine;
altretamine;
HTM;
Hemel;
2,4,6-tris-1,3,5-triazine;
Hexylen;
hemel
- CAS No.:645-05-6
- 分子式:
C9H18N6
- 分子量:210.28
- 精确分子量:210.15900
- PSA:48.39000
- MDL:MFCD00549245
- InChI:InChI=1/C9H24N6/c1-10(2)13-7-14(11(3)4)9-15(8-13)12(5)6/h7-9H2,1-6H3
- 分子结构式:
物化性质
- 外观与性状:
- 无色结晶固体
- 密度:
- 1.148 g/cm3
- 熔点:
- 171-175 °C(lit.)
- 沸点:
- 301ºC
- 闪点:
- 159.1ºC
- 水溶解性:
- Insoluble
- 折射率:
- 1.569
- 存储条件/存储方法:
常温,2-8℃,避光,通风干燥处
- 稳定性相关:
白色针状结晶。熔点170-173℃,易溶于
氯仿,微溶于甲醇、乙醇,极微溶于水,对酸碱稳定。具升华性
- 其它信息:
1. 性状:白色针状结晶
2. 密度(g/mL,25/4℃):
3. 相对蒸汽密度(g/mL,空气=1):
4. 熔点(ºC):171-175
5. 沸点(ºC,常压):301
6. 沸点(ºC,5.2kPa):未确定
7. 折射率:
8. 闪点(ºC):
9. 比旋光度(º):
10. 自燃点或引燃温度(ºC):
11. 蒸气压(kPa,25ºC):
12. 饱和蒸气压(kPa,60ºC):
13. 燃烧热(KJ/mol):
14. 临界温度(ºC):
15. 临界压力(KPa):
16. 油水(辛醇/水)分配系数的对数值:
17. 爆炸上限(%,V/V):
18. 爆炸下限(%,V/V):
19. 溶解性:不溶于水
安全信息
- 外观与性状:
- 无色结晶固体
- 密度:
- 1.148 g/cm3
- 熔点:
- 171-175 °C(lit.)
- 沸点:
- 301ºC
- 闪点:
- 159.1ºC
- 水溶解性:
- Insoluble
- 折射率:
- 1.569
- 存储条件/存储方法:
常温,2-8℃,避光,通风干燥处
- 稳定性相关:
白色针状结晶。熔点170-173℃,易溶于
氯仿,微溶于甲醇、乙醇,极微溶于水,对酸碱稳定。具升华性
- 其它信息:
1. 性状:白色针状结晶
2. 密度(g/mL,25/4℃):
3. 相对蒸汽密度(g/mL,空气=1):
4. 熔点(ºC):171-175
5. 沸点(ºC,常压):301
6. 沸点(ºC,5.2kPa):未确定
7. 折射率:
8. 闪点(ºC):
9. 比旋光度(º):
10. 自燃点或引燃温度(ºC):
11. 蒸气压(kPa,25ºC):
12. 饱和蒸气压(kPa,60ºC):
13. 燃烧热(KJ/mol):
14. 临界温度(ºC):
15. 临界压力(KPa):
16. 油水(辛醇/水)分配系数的对数值:
17. 爆炸上限(%,V/V):
18. 爆炸下限(%,V/V):
19. 溶解性:不溶于水
毒理性
CHEMICAL IDENTIFICATION
- RTECS NUMBER :
- OS1050000
- CHEMICAL NAME :
- Melamine, hexamethyl-
- CAS REGISTRY NUMBER :
- 645-05-6
- BEILSTEIN REFERENCE NO. :
- 0195058
- LAST UPDATED :
- 199612
- DATA ITEMS CITED :
- 26
- MOLECULAR FORMULA :
- C9-H18-N6
- MOLECULAR WEIGHT :
- 210.33
- WISWESSER LINE NOTATION :
- T6N CN ENJ BN1&1 DN1&1 FN1&1
HEALTH HAZARD DATA
ACUTE TOXICITY DATA
- TYPE OF TEST :
- TDLo - Lowest published toxic dose
- ROUTE OF EXPOSURE :
- Oral
- SPECIES OBSERVED :
- Human
- DOSE/DURATION :
- 8 mg/kg
- TOXIC EFFECTS :
- Gastrointestinal - nausea or vomiting Blood - leukopenia
- TYPE OF TEST :
- LD50 - Lethal dose, 50 percent kill
- ROUTE OF EXPOSURE :
- Oral
- SPECIES OBSERVED :
- Rodent - rat
- DOSE/DURATION :
- 350 mg/kg
- TOXIC EFFECTS :
- Details of toxic effects not reported other than lethal dose value
- TYPE OF TEST :
- LD50 - Lethal dose, 50 percent kill
- ROUTE OF EXPOSURE :
- Intraperitoneal
- SPECIES OBSERVED :
- Rodent - rat
- DOSE/DURATION :
- 265 mg/kg
- TOXIC EFFECTS :
- Details of toxic effects not reported other than lethal dose value
- TYPE OF TEST :
- LD50 - Lethal dose, 50 percent kill
- ROUTE OF EXPOSURE :
- Oral
- SPECIES OBSERVED :
- Rodent - mouse
- DOSE/DURATION :
- 437 mg/kg
- TOXIC EFFECTS :
- Sense Organs and Special Senses (Eye) - chromodacryorrhea Blood - hemorrhage
- TYPE OF TEST :
- LD10 - Lethal Dose
- ROUTE OF EXPOSURE :
- Intraperitoneal
- SPECIES OBSERVED :
- Rodent - mouse
- DOSE/DURATION :
- 200 mg/kg
- TOXIC EFFECTS :
- Blood - granulocytopenia Blood - changes in bone marrow (not otherwise specified)
- TYPE OF TEST :
- LD50 - Lethal dose, 50 percent kill
- ROUTE OF EXPOSURE :
- Intravenous
- SPECIES OBSERVED :
- Rodent - mouse
- DOSE/DURATION :
- 171 mg/kg
- TOXIC EFFECTS :
- Cardiac - cardiomyopathy including infarction Liver - hepatitis (hepatocellular necrosis), zonal
- TYPE OF TEST :
- LDLo - Lowest published lethal dose
- ROUTE OF EXPOSURE :
- Intravenous
- SPECIES OBSERVED :
- Mammal - dog
- DOSE/DURATION :
- 100 mg/kg
- TOXIC EFFECTS :
- Blood - pigmented or nucleated red blood cells Blood - changes in leukocyte (WBC) count Biochemical - Enzyme inhibition, induction, or change in blood or tissue levels - transaminases
- TYPE OF TEST :
- LD50 - Lethal dose, 50 percent kill
- ROUTE OF EXPOSURE :
- Oral
- SPECIES OBSERVED :
- Rodent - guinea pig
- DOSE/DURATION :
- 255 mg/kg
- TOXIC EFFECTS :
- Details of toxic effects not reported other than lethal dose value
- TYPE OF TEST :
- LD50 - Lethal dose, 50 percent kill
- ROUTE OF EXPOSURE :
- Oral
- SPECIES OBSERVED :
- Bird - chicken
- DOSE/DURATION :
- 341 mg/kg
- TOXIC EFFECTS :
- Peripheral Nerve and Sensation - flaccid paralysis without anesthesia (usually neuromuscular blockage) Behavioral - ataxia
- TYPE OF TEST :
- TDLo - Lowest published toxic dose
- ROUTE OF EXPOSURE :
- Oral
- SPECIES OBSERVED :
- Rodent - rat
- DOSE/DURATION :
- 3080 mg/kg/77D-I
- TOXIC EFFECTS :
- Gastrointestinal - changes in structure or function of endocrine pancreas Endocrine - hyperglycemia Related to Chronic Data - death
- TYPE OF TEST :
- TDLo - Lowest published toxic dose
- ROUTE OF EXPOSURE :
- Intraperitoneal
- SPECIES OBSERVED :
- Rodent - rat
- DOSE/DURATION :
- 625 mg/kg/5D-I
- TOXIC EFFECTS :
- Related to Chronic Data - death
- TYPE OF TEST :
- TDLo - Lowest published toxic dose
- ROUTE OF EXPOSURE :
- Intraperitoneal
- SPECIES OBSERVED :
- Rodent - mouse
- DOSE/DURATION :
- 625 mg/kg/5D-I
- TOXIC EFFECTS :
- Related to Chronic Data - death
- TYPE OF TEST :
- TDLo - Lowest published toxic dose
- ROUTE OF EXPOSURE :
- Intravenous
- SPECIES OBSERVED :
- Mammal - dog
- DOSE/DURATION :
- 250 mg/kg/5D-I
- TOXIC EFFECTS :
- Blood - changes in bone marrow (not otherwise specified) Blood - other changes Related to Chronic Data - death
- TYPE OF TEST :
- TDLo - Lowest published toxic dose
- ROUTE OF EXPOSURE :
- Oral
- SPECIES OBSERVED :
- Human - woman
- DOSE/DURATION :
- 3108 mg/kg/3Y-I
- TOXIC EFFECTS :
- Tumorigenic - equivocal tumorigenic agent by RTECS criteria Blood - leukemia
- TYPE OF TEST :
- TDLo - Lowest published toxic dose
- ROUTE OF EXPOSURE :
- Oral
- SPECIES OBSERVED :
- Rodent - rat
- DOSE/DURATION :
- 7 gm/kg/46W-C
- TOXIC EFFECTS :
- Tumorigenic - neoplastic by RTECS criteria Kidney, Ureter, Bladder - Kidney tumors Skin and Appendages - tumors
- TYPE OF TEST :
- TDLo - Lowest published toxic dose
- ROUTE OF EXPOSURE :
- Oral
- DOSE :
- 1240 mg/kg
- SEX/DURATION :
- male 62 day(s) pre-mating
- TOXIC EFFECTS :
- Reproductive - Paternal Effects - testes, epididymis, sperm duct Reproductive - Fertility - male fertility index (e.g. # males impregnating females per # males exposed to fertile nonpregnant females) Reproductive - Fertility - post-implantation mortality (e.g. dead and/or resorbed implants per total number of implants)
- TYPE OF TEST :
- TDLo - Lowest published toxic dose
- ROUTE OF EXPOSURE :
- Oral
- DOSE :
- 320 mg/kg
- SEX/DURATION :
- female 6-9 day(s) after conception
- TOXIC EFFECTS :
- Reproductive - Fertility - post-implantation mortality (e.g. dead and/or resorbed implants per total number of implants) Reproductive - Fertility - litter size (e.g. # fetuses per litter; measured before birth)
- TYPE OF TEST :
- TDLo - Lowest published toxic dose
- ROUTE OF EXPOSURE :
- Oral
- DOSE :
- 320 mg/kg
- SEX/DURATION :
- female 9-12 day(s) after conception
- TOXIC EFFECTS :
- Reproductive - Effects on Embryo or Fetus - fetotoxicity (except death, e.g., stunted fetus)
- TYPE OF TEST :
- TDLo - Lowest published toxic dose
- ROUTE OF EXPOSURE :
- Oral
- DOSE :
- 1160 mg/kg
- SEX/DURATION :
- female 15-22 day(s) after conception lactating female 21 day(s) post-birth
- TOXIC EFFECTS :
- Reproductive - Effects on Newborn - viability index (e.g., # alive at day 4 per # born alive) Reproductive - Effects on Newborn - weaning or lactation index (e.g., # alive at weaning per # alive at day 4)
- TYPE OF TEST :
- TDLo - Lowest published toxic dose
- ROUTE OF EXPOSURE :
- Oral
- DOSE :
- 80 mg/kg
- SEX/DURATION :
- female 15-22 day(s) after conception
- TOXIC EFFECTS :
- Reproductive - Effects on Newborn - growth statistics (e.g.%, reduced weight gain)
- TYPE OF TEST :
- TDLo - Lowest published toxic dose
- ROUTE OF EXPOSURE :
- Oral
- DOSE :
- 780 mg/kg
- SEX/DURATION :
- female 6-18 day(s) after conception
- TOXIC EFFECTS :
- Reproductive - Effects on Embryo or Fetus - fetotoxicity (except death, e.g., stunted fetus)
- TYPE OF TEST :
- Sex chromosome loss and nondisjunction
- TYPE OF TEST :
- Cytogenetic analysis
MUTATION DATA
- TYPE OF TEST :
- DNA damage
- TEST SYSTEM :
- Mammal - species unspecified Lymphocyte
- DOSE/DURATION :
- 250 umol/L
- REFERENCE :
- CNREA8 Cancer Research. (Public Ledger Building, Suit 816, 6th & Chestnut Sts., Philadelphia, PA 19106) V.1- 1941- Volume(issue)/page/year: 43,500,1983
- 生态数据:
通常对水是不危害的,若无政府许可,勿将材料排入周围环境
海关数据
中国海关编码:2933699090
- 概述:
- 2933699090 其他结构上含非稠合三嗪环化合物. 增值税率:17.0% 退税率:9.0% 监管条件:无 最惠国关税:6.5% 普通关税:20.0%
- 申报要素:
- 品名, 成分含量, 用途, 乌洛托品请注明外观, 6-己内酰胺请注明外观, 签约日期
- 摘要/Summary:
- 2933699090 other compounds containing an unfused triazine ring (whether or not hydrogenated) in the structure。Supervision conditions:None。VAT:17.0%。Tax rebate rate:9.0%。MFN tariff:6.5%。General tariff:20.0%
分子结构与计算化学数据
计算化学数据
1.疏水参数计算参考值(XlogP):无
2.氢键供体数量:0
3.氢键受体数量:6
4.可旋转化学键数量:3
5.互变异构体数量:无
6.拓扑分子极性表面积48.4
7.重原子数量:15
8.表面电荷:0
9.复杂度:148
10.同位素原子数量:0
11.确定原子立构中心数量:0
12.不确定原子立构中心数量:0
13.确定化学键立构中心数量:0
14.不确定化学键立构中心数量:0
15.共价键单元数量:1